Replies to post #9670 on DarioHealth Corp (DRIO)

[x1power]

I am surprised DRIO has not invited some USA diabetic health care professionals and patients down to say Mexico, to show them their device.

FDA might want as many as 5-10,000 device readings, to compare records, of current finger pickle diabetic readers now on the market. I would like to see DRIO FDA device approved by end of 2014, however they may want additional data accuracy and device reliability in mobile use mode. FDA is going to have to be careful herein, as DRIO does want to manufacture other type bodily fluid readers. FDA is on the line here.

I am thinking NOV or DEC or Jan 2015 for FDA approval . . . lets see how early Oct date comes out.

DRIO mobile diabetic reader could be big PR potential for increasing efficiency and consumer confidence in USA new health care system. Mobile internet based health reader devices could be big in future of health care.

Stock volume has fallen way down, as well as Y Board and this board daily comments.
You are not going to get .20-.50 DRIO stock price before R/Split, without one or more dramatic PRs. Though . . . company insiders or large public vetted investment house DRIO stock purchases sure might be helpful in this regard.

Why not donate some DRIO readers, to a military unit for testing on its personnel?
Long duration, intense pressure situations (like combat), can be a contributing factor to individual health status factors, and 'drain' the ability of immune system to regulate properly various bodily organ functions. It is felt by many health care researchers, that stress is a contributor to immune deficient disease effects on humans. Meaning, a reduced efficiency immune system, is a component factor in virtually all diseases.


Imagine if DRIO prototyped a Ebola reader SW program, that was connected to its reader and had a visual enlargement display that duplicated a microscope view of the virus? The enlargement power lens of a micro video camera and spectral specific filter, would create a very interesting reader device.

This could lead to other visual evidence SW enlargement programs, for other diseases like TB. User would add chemicals to blood scan and then blow them up on the auxiliary attachment device, connected to the DRIO reader. Using microchip blood sample disease specific analysis, as these are already out in use at blood labs.

This might result in R and D assistance and a grant from someone like DARPA or HLS or Energy Administration. What a great funding source to help propel the stock price. That kind of PR substance would be useful.

I suspect DRIO reads this board. I would, as few stock boards around for DRIO.